Trimi

✨ NEW
No Membership Fees!

✨ NEW

Compounded Tirzepatide Now Available →

Ask ChatGPT

Tirzepatide merges the effects of GLP-1 and GIP hormones to support improved blood sugar regulation and promote weight reduction. Discover how it works, its unique benefits, and how it compares to semaglutide as part of your health journey with TryTrimi.

The U.S. Food and Drug Administration (FDA) has officially removed compounded tirzepatide—the active component found in brand-name drugs like Mounjaro® and Zepbound®—from its shortage list. Due to this, compounding pharmacies in the U.S. will soon no longer be permitted to produce tirzepatide-based formulations.

There is currently a 60-day grace period during which individuals can still consult with their doctors and obtain compounded tirzepatide. After that, compounded tirzepatide will no longer be accessible from pharmacies unless under exceptional conditions.

At TryTrimi, we understand how critical this treatment is for many on their weight loss path. That’s why we’ve partnered with independent medical professionals to offer a solution. For a limited time, you may be eligible for up to a 6-month prescription of compounded tirzepatide. This opportunity is only available for the next 60 days, so it’s important to act quickly and explore your options with a licensed provider.

We’re here to help support your wellness and weight goals during this transition period with care and reliability.

The FDA has confirmed that tirzepatide has been taken off the national drug shortage list. As a result, compounding pharmacies are no longer authorized to manufacture this medication under current federal guidelines.

This means that TryTrimi can no longer provide access to compounded tirzepatide through its partner pharmacies.

We understand how this may raise concerns—especially for users who have relied on this accessible treatment. Please know that we are committed to a smooth and worry-free transition toward other effective treatment alternatives. Read our updated coverage on the recent tirzepatide availability update.

For Current TryTrimi Members: Transitioning to Semaglutide

If you’ve been using compounded tirzepatide through TryTrimi, you may be impacted by this change. We’re working hard to ensure your continuity of care by offering other options, such as compounded semaglutide—the active ingredient in Ozempic and Wegovy.

Why Is This Change Happening?

Tirzepatide gained popularity as a reliable medication for weight control. However, with its removal from the FDA’s shortage list, compounded versions are now federally prohibited. By law, compounding is only allowed for drugs currently listed as being in short supply.

Now that supply issues are resolved, compounding pharmacies must stop producing tirzepatide.

TryTrimi is dedicated to ensuring your care isn’t interrupted. That’s why we now offer access to a range of weight loss treatments, including semaglutide in its compounded form.

Tirzepatide vs. Semaglutide – What’s the Difference?

Both medications are effective in managing weight and regulating appetite by influencing how the body processes sugar.

  • Semaglutide mimics the GLP-1 hormone, signaling to the brain that you’re full and helping slow digestion so you feel satisfied longer.
  • Tirzepatide performs this same action but also stimulates the GIP hormone, enhancing its effects.

Semaglutide remains a proven and widely-used treatment for those on a weight management plan. It may be an excellent next step in reaching your goals.

What You Should Know

  • Cost-Friendly Options: Compounded semaglutide continues to be available and may be a more economical alternative.
  • No Service Gaps: We’re doing everything possible to maintain consistent access to your treatments. For any concerns or questions about switching from tirzepatide to semaglutide, contact us via your TryTrimi portal.
  • Support Every Step of the Way: Our care team is here to make sure your transition is smooth and well-supported.

We know that changing medications can feel uncertain, but many have experienced success with semaglutide. It may offer you the same level of benefit moving forward.

Note: Semaglutide is only available by prescription after an online consultation. Our plans operate as a subscription service and can be canceled at any time. Medication appearance may vary. The FDA does not evaluate compounded medications for safety or effectiveness. Visit our site for complete safety info.

How to Take Tirzepatide: Dosing & Administration Guide

Tirzepatide is administered once weekly via a subcutaneous injection, meaning it’s injected under the skin—commonly in the abdomen, upper arm, or thigh. It’s available in easy-to-use, pre-filled injection pens, like those used in popular brand-name products such as Zepbound® and Mounjaro®.

Most people begin their treatment at a low dose of 2.5 mg per week, with the potential to gradually increase to a maintenance dose between 5 mg and 10 mg—though some may go up to 15 mg depending on individual needs and tolerability.

Suggested Tirzepatide Titration Schedule

Tirzepatide is typically titrated—meaning the dose is slowly increased over time to reduce side effects and find the right balance for your body. A common dosing plan looks like this:

  • Month 1: 2.5 mg
  • Month 2: 5 mg
  • Month 3: 7.5 mg
  • Month 4: 10 mg

Healthcare providers may adjust this plan based on how you respond to the medication.

What Is Titration and Why Does It Matter?

Titration refers to the gradual adjustment of a drug’s dosage. In the case of tirzepatide, starting at a low dose and slowly increasing it can help minimize side effects like nausea or digestive discomfort. This step-by-step approach helps your body adjust to the medication while still delivering results.

Most patients increase their dose every four weeks under the supervision of a healthcare provider until the optimal dose (5 mg to 15 mg) is reached for sustained benefits.

Tirzepatide vs. Semaglutide: What’s the Difference?

Both tirzepatide and semaglutide are GLP-1 based treatments designed to support weight loss and regulate blood sugar levels. However, tirzepatide stands out by also targeting GIP receptors, giving it a dual-action advantage.

Studies—including one published in the New England Journal of Medicine—have shown that tirzepatide leads to greater weight loss compared to semaglutide, making it a strong contender for those looking to improve both metabolic and weight-related outcomes.

That said, both medications can have similar side effects—mostly mild gastrointestinal issues such as nausea or diarrhea. Tirzepatide may have a slightly higher chance of more intense side effects at larger doses.

Ultimately, the best option depends on your body’s response and personal preferences. Your provider can help decide which therapy fits best into your plan.

Always Talk to Your Doctor First

Before starting tirzepatide—or any prescription medication—it’s essential to speak with a qualified medical professional. Your health history, current medications, and personal goals all play a role in choosing the right treatment path.

At TryTrimi, we make it easy to connect with licensed healthcare providers who can guide you through a personalized plan. FDA-approved options like Zepbound® and Mounjaro®, as well as compounded tirzepatide, are available online for eligible users.

Get Started With Semaglutide

If tirzepatide isn’t right for you, or you need an alternative, semaglutide is also a trusted option for long-term weight support. Talk with your provider to explore what’s best for your health needs.

Disclaimer

The content provided here is for informational purposes only and is not meant to replace professional medical advice, diagnosis, or treatment. Always consult a licensed healthcare provider before starting or changing any medication.

Please note that compounded medications are not evaluated by the FDA for quality, safety, or effectiveness. Your prescription and health plan must be determined by a licensed provider through consultation.

TryTrimi does not manufacture, own, or dispense medications. All prescriptions are written by independent licensed providers and filled by state-licensed pharmacies.

In recent years, personalized weight loss treatments have garnered significant attention for their ability to provide tailored solutions that cater to individual needs. One such treatment that has shown remarkable promise is compounded Semaglutide. Originally developed for managing type 2 diabetes, Semaglutide has been repurposed for weight loss due to its ability to effectively regulate appetite and promote substantial weight reduction. This comprehensive guide delves into the benefits of compounded Semaglutide and how it can aid in achieving your weight loss goals.

What is Compounded Semaglutide?

Compounded Semaglutide is a customized formulation of the medication Semaglutide, tailored to meet the specific needs of an individual patient. Semaglutide works by mimicking the GLP-1 hormone, which plays a crucial role in regulating appetite and blood sugar levels. Compounding refers to the process of creating a personalized dosage and formulation of the medication, ensuring that it is optimized for the patient’s unique health profile and weight loss requirements. This personalized approach not only enhances the effectiveness of the treatment but also minimizes potential side effects.

The Science Behind Semaglutide

Semaglutide is part of a class of medications known as GLP-1 receptor agonists. These medications work by mimicking the GLP-1 hormone, which is naturally produced in the gut and helps regulate appetite, insulin secretion, and blood sugar levels. By activating GLP-1 receptors in the brain, Semaglutide helps reduce hunger and increase feelings of fullness, leading to reduced calorie intake and weight loss. Clinical studies have shown that Semaglutide can lead to significant weight loss, making it a valuable tool for individuals struggling with obesity and weight management issues.

Benefits of Using Compounded Semaglutide

  1. Personalized Dosage and Formulation: One of the primary benefits of compounded Semaglutide is the ability to customize the dosage and formulation to meet the specific needs of the patient. This personalized approach ensures that the medication is highly effective and well-tolerated.
  2. Reduced Risk of Side Effects: By tailoring the dosage to the individual, compounded Semaglutide minimizes the risk of side effects that can occur with standard, one-size-fits-all dosages. This personalized approach ensures a safer treatment experience.
  3. Enhanced Effectiveness: Compounded Semaglutide has been shown to be more effective in reducing appetite and promoting weight loss compared to standard formulations. This is due to the precise customization of the medication to suit the patient’s unique metabolic needs.
  4. Long-Term Benefits for Metabolic Health: In addition to promoting weight loss, compounded Semaglutide can improve overall metabolic health by regulating blood sugar levels and reducing the risk of obesity-related conditions such as type 2 diabetes and cardiovascular disease.

The Trimi Approach to Weight Loss

Try Trimi offers a unique approach to weight loss by incorporating compounded Semaglutide into its personalized treatment plans. The process begins with a comprehensive health assessment, which includes a detailed online quiz and a virtual consultation with a licensed healthcare provider. Based on this assessment, a customized treatment plan is developed, which includes a prescription for compounded Semaglutide. Trimi’s approach ensures that each patient receives a treatment plan that is tailored to their specific needs, maximizing the effectiveness of the medication and enhancing the overall weight loss experience.

Success Stories and Testimonials

Many individuals have experienced significant weight loss and improved health with the help of compounded Semaglutide and Trimi’s personalized approach. Success stories highlight the convenience and effectiveness of the treatment, with patients reporting substantial weight loss and improved quality of life. Testimonials from satisfied clients emphasize the benefits of personalized care and continuous support from Trimi’s medical team, which plays a crucial role in maintaining motivation and achieving long-term weight loss goals.

Getting Started with Compounded Semaglutide

Starting your weight loss journey with compounded Semaglutide through Try Trimi is a straightforward and user-friendly process:

  1. Health Assessment: Begin by completing an online health assessment to provide insights into your medical history and weight loss goals.
  2. Consultation: Engage in a virtual consultation with a healthcare provider to discuss your health needs and determine the suitability of compounded Semaglutide.
  3. Personalized Treatment Plan: Receive a customized treatment plan that includes a prescription for compounded Semaglutide, tailored to your specific needs.
  4. Medication Delivery: Enjoy the convenience of having your medication delivered directly to your doorstep, ensuring a hassle-free experience.
  5. Ongoing Support: Benefit from continuous support and regular check-ins with medical professionals to monitor your progress and make necessary adjustments to your treatment plan.

Conclusion

Compounded Semaglutide offers a highly effective and personalized solution for weight loss, providing significant benefits over standard treatments. By tailoring the medication to meet individual needs, patients can achieve substantial weight loss and improve their overall metabolic health. Try Trimi’s innovative approach to weight loss, which includes personalized treatment plans, convenient online consultations, and continuous support, makes it an ideal choice for those seeking a sustainable and effective weight loss solution. Start your journey with Try Trimi today and experience the transformative benefits of compounded Semaglutide.

CONTACT US

    PRODUCTS

    SEARCH

    WARNING

    Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

    • Severe nausea and/or vomiting resulting in dehydration - it is important to stay well hydrated and drink plenty of fluids while on this medication. Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis.
    • Thyroid C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below).
    • Pancreatitis: Severe pain in your abdomen or back that will not go away.
    • Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
    • Hepatitis/Elevated liver enzymes/Jaundice
    • Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy.
    • Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
    • Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness). While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (i.e. sulfonylurea such as Glipizide, glimepiride, and glyburide) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
    • Increasing heart rate
    • Worsening depression, behavior changes, or suicidality

    Never share the semaglutide with other people

    Drug Interactions

    As with other medications, oral semaglutide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Oral semaglutide delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting oral semaglutide, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on oral semaglutide.

    Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

    To report suspected adverse reactions to o semaglutide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

    In case of emergencies, please call 911 or go to the nearest emergency room.

    Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

    This will close in 0 seconds

    GLP-1 Rx Gummies

    *Compounded medications may be prescribed by physicians but have not been FDA regulated for safety, effectiveness, or quality. FDA-approved medicines containing semaglutide are available.

     

    WARNING

     

    Please contact your doctor ASAP and seek in-person care immediately if a side effect becomes problematic or you experience:

    • Severe nausea and/or vomiting resulting in dehydration -  it is important to stay well hydrated and drink plenty of fluids while on this medication.
    • Kidney problems/kidney failure - vomiting, nausea, diarrhea can cause dehydration and kidney issues and make kidney problems worse in individuals who have pre-existing kidney conditions; may sometimes lead to the need for hemodialysis.
    • Thyroid C-Cell Tumor: Trouble swallowing, hoarseness, a lump or swelling in your neck, or shortness of breath (see black box warning below).
    • Pancreatitis: Severe pain in your abdomen or back that will not go away.
    • Acute gallbladder disease - Pain in the middle or right upper stomach, fever, white parts of your eyes turn yellow or skin turns yellow, nausea/vomiting. If gallstones or inflammation of the gallbladder is suspected further studies are needed.
    • Hepatitis/Elevated liver enzymes/Jaundice
    • Diabetic retinopathy problems: Changes in vision in those with type II diabetes, particularly vision problems may worsen in those with a history of diabetic retinopathy.
    • Severe gastrointestinal disease - may cause gastrointestinal disease; do not use if you have a history of severe gastrointestinal disease
    • Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness). While this is rare with GLP-1s, if it occurs, please seek in-person care immediately. If you have these symptoms, try having liquid or food containing sugar (around 15-20 grams) —drinking juice, having regular soda, or eating some hard candies right away, as this will help raise your blood sugar quickly. If taken with insulin or an insulin secretagogue (i.e. sulfonylurea such as Glipizide, glimepiride, and glyburide) it is best to talk to your healthcare provider about possibly lowering the dose of these medications to lower the risk of hypoglycemia.
    • Increasing heart rate
    • Worsening depression, behavior changes, or suicidality
    • Never share the semaglutide with other people

    Drug Interactions

     

    As with other medications, oral semaglutide can interact with alcohol and certain prescription and non-prescription medications and herbal products. The risk of hypoglycemia is increased when combined with insulin or insulin secretagogues such as sulfonylureas. Oral semaglutide delays gastric emptying and may impact the absorption of oral medications. If you are on thyroid hormone medication, prior to starting oral semaglutide, please review the timing of taking your thyroid hormone medication with the doctor who prescribes it as it may need to be adjusted. The drug levels of medications with narrow therapeutic windows (ie warfarin) should be monitored closely while on oral semaglutide.

    Please consult the pharmaceutical packaging for a full list of side effects, warnings, interactions and additional information.

    To report suspected adverse reactions to o semaglutide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

    In case of emergencies, please call 911 or go to the nearest emergency room.

     

    This will close in 0 seconds

    Scroll to Top